21. Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients. (February 2019) Authors: Younes, R.; Rosso, C.; Blanco, M.J. Garcia; Petta, S.; Miele, L.; Liguori, A.; Francione, P.; Fracanzani, A.; Valenti, L.; Anstee, Q.M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Low adherence to Mediterranean Diet is associated to sCD163 levels in patients with MAFLD. (March 2023) Authors: Perez-Diaz-del-Campo, N.; Rosso, C.; Caviglia, G.P.; Castelnuovo, G.; D'Amato, D.; Abdulle, A.; Guariglia, M.; Armandi, A.; Olivero, A.; Abate, M.L.; Saracco, G.M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort. (March 2023) Authors: D'Amato, D.; Tore, D.; Rosso, C.; Armandi, A.; Castelnuovo, G.; Abdulle, A.; Gjni, K.; Diaz del Campo, N. Perez; Guariglia, M.; Caviglia, G.P.; Gatti, M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. MBOAT7 locus rs641738 variant predisposes to hepatocellular carcinoma in nonalcoholic fatty liver. (10th February 2016) Authors: Donati, B.; Dongiovanni, P.; Miele, L.; Rosso, C.; Maier, S.; Petta, S.; Meroni, M.; De Luca, L.; Grimaudo, S.; Romagnoli, R.; Colli, F.; Craxi, A.; Grieco, A.; Bugianesi, E.; Fargion, S.; Fracanzani, A.L.; Soardo, G.; Valenti, L. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Metabolic Syndrome after liver transplantation: have risk factors changed over time?. (15th February 2015) Authors: Vanni, E.; Jouness, R. Ibrahim Kamal; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Metabolomic profile of morbidly obese NAFLD: effect of weight loss by exenatide or diet. (February 2019) Authors: Patrício, B.; Gaggini, M.; Carli, F.; Astiarraga, B.; Rosso, C.; Ferrannini, E.; Bugianesi, E.; Camastra, S.; Gastaldelli, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2α. (February 2019) Authors: Foglia, B.; Sutti, S.; Morello, E.; Cannito, S.; Novo, E.; Bocca, C.; Maggiora, M.; Bruzzì, S.; Ramavath, N.N.; Rosso, C.; Younes, R.; Bugianesi, E.; Albano, E.; Parola, M. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. OC-07A machine learning approach for the classification of NASH vs NAFL in diabetic and non-diabetic subjects reveals a strong association between liver inflammation and adipose tissue dysfunction. (October 2021) Authors: Sabatini, S.; Gaggini, M.; Allison, M.; Younes, R.; Rosso, C.; Schattenberg, J.M.; Ratziu, V.; Bugianesi, E.; Anstee, Q.M.; Gastaldelli, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 4 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response. (March 2023) Authors: Foglia, B.; Cannito, S.; Sutti, S.; Nurcis, J.; Turato, C.; Maggiora, M.; Doto, F.; Rosso, C.; Carucci, P.; Gaia, S.; Biasiolo, A.; Pontisso, P.; Bugianesi, E.; Albano, E.; Parola, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Oncostatin M, a novel profibrogenic mediator, is involved in the progression non-alcoholic fatty liver disease and stimulates migration of myofibroblasts. (February 2020) Authors: Foglia, B.; Novo, E.; Sutti, S.; Cannito, S.; Protopapa, F.; Bocca, C.; Maggiora, M.; Rosso, C.; Bugianesi, E.; Albano, E.; Parola, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗